4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-315989
Options or other derivatives
- Chief Financial Officer acquired 480,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Humer Kristian · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-09 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +480,000 | 480,000 | D |
Loading xslF345X05/ownership.xml…